@article{Licona Vera_Pérez Padilla_Torrens Soto_Abuabara Franco_Caballero Rodriguez_Cerda Salcedo_Ramos Clason_Caballero Rodriguez_Hoyos Montaño_Morales Jurado_Pabón Vera_Serna Vera_2020, title={Clinical and metabolic characterization of patients with a diagnosis of urolithiasis in a four-level clinic in the city of Barranquilla: Caracterización clínica y metabólica depacientes con diagnóstico de urolitiasisatendidos en una clínica de cuarto nivel deBarranquilla, Colombia}, volume={8}, url={https://revistanefrologia.org/index.php/rcn/article/view/472}, DOI={10.22265/acnef.8.1.472}, abstractNote={<p><strong>Introduction:</strong><br />Urolithiasis is a disease with high frequency and our environment is no exception. Previous studies have been published in Colombia, however, these do not compare the sociodemographic and clinical characteristics of patients with comorbidities and predisposing factors for lithiasis such as they are hyperuricemia, high blood pressure, obesity, and chronic kidney disease (CKD).</p> <p><strong>Objectives:</strong></p> <p>To characterize clinically and metabolically the patients diagnosed with urolithiasis in a fourth-level clinic in the city of Barranquilla in 2019.</p> <p> </p> <p><strong>Materials and methods:</strong><br />Observational, descriptive, cross-sectional study. In 49 patients, based on the study of clinical records.</p> <p><strong>Results:</strong><br />The median age was 58 years, the male sex in 53.1 %. The median body mass index was 26.4 Kg/m<sup>2</sup>. High blood pressure was identified in 69.4 %, chronic kidney disease (CKD) in 36.7 %, recurrent urinary tract infection in 24.5 %. Hyperuricemia in 44.9 %, hypercalcemia in 16.3 % and hyperphosphatemia in 12.2 %. The crystal types were oxalate in 20.4 %, urate in 12.2 %, mixture of the previous ones in 4.1 % and in the same proportion phosphate. Hypercalciuria and hyperoxaluria in 38.8 %, hyperuricosuria and hypocalciuria in 18.4 %, while hyperphosphaturia or hypophosphaturia in 4.1 %. Hyperuricemia was associated with age (p = 0.028), CKD (p = 0.026), antihypertensive drugs (p = 0.022), the position of the stone in the renal calyx (p = 0.012), hyperparathyroidism (p = 0.007), creatinine clearance (p = 0.046) and hypercalciuria (p = 0.049). BMI ? 30 was associated with stage 5 CKD (p = 0.025), dialysis (p = 0.025), and hyperoxaluria (p = 0.021).</p> <p><strong>Conclusions:</strong> <br />A significant frequency of CKD, hyperuricemia, obesity and hypertension was evidenced in patients with urolithiasis.</p>}, number={1}, journal={Revista Colombiana de Nefrología}, author={Licona Vera, Erick Ricardo and Pérez Padilla, Rafael Vicente and Torrens Soto, Jeison Enrique and Abuabara Franco, Emilio and Caballero Rodriguez, Luis Ricardo and Cerda Salcedo, Jose Eduardo and Ramos Clason, Enrique Carlos and Caballero Rodriguez, Carlos Javier and Hoyos Montaño, Ingrith Paola and Morales Jurado, Luis Fernando and Pabón Vera, Fabian Andrés and Serna Vera, Juan Carlos}, year={2020}, month={Dec.}, pages={e472} }